Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by deficits in social communication, restricted interests, and repetitive behaviors. The prevalence of ASD has raised concerns recently, and this article aims to explore various factors that may influence its rates, including changes in diagnostic criteria. ASD is a neurobiological disorder influenced by a combination of genetic and environmental factors that affect the developing brain.

ASDs are complex and heterogeneous neurodevelopmental conditions characterized by core domains, including persistent deficits in social communication and interaction, as well as restricted and repetitive patterns of behavior, interests, or activities. These disorders often involve inflammatory conditions and dysfunction in the immune system. Given the neurobiological changes associated with ASD development, there has been interest in exploring cell-based therapies. Stem cells, in particular, possess specific immunological properties that make them promising candidates for ASD treatment.


Three innovative treatments combined to create a revolutionary and unique protocol to approach autism spectrum disorder.

In a world full of different information, with parents dedicated to improving the quality of their children’s lives, time, resources, and hope are often wasted as the parent is forced to improvise without reliable guidance.

The purpose of our ABC protocol is to reach the maximum healing potential of each one of our patients by creating a unique protocol that includes the three essential areas of intervention: immunomodulation, regeneration and stimulation with the potential of enhancing each other. All this is done taking into account the correct order and time to perform each one of these interventions, based on more than 17 years of research, studies and experience.

The ABC protocol is monitored with brain imaging, via quantitative EEG, or brain mapping, which is a technique that allows us to record brain communication patterns that are established by the measurement of bioelectric activity, before starting the protocol, during the protocol and at the end to be able to demonstrate the evolution of the patient.


This part of the process is provided by Aflora Medical Center which is  dedicated to the research of the human microbiome, focusing on the brain gut connection, and how this affects behavior and neurodevelopment, understanding the microbiome as a key component of the health-disease process.

The Human Microbiome represents life within us, it is the set of bacteria that inhabit our entire body and that we inherit from our parents and from past generations. The microbiome changes generationally, affected mainly by the environmental changes to which each generation is exposed. These bacteria are more than an organ, they are our human essence itself, and it must be in perfect balance for us to be healthy. It is composed of beneficial bacteria and non-beneficial bacteria that balanced allow a fully healthy human.

Aflora has achieved over 17 years of expertise in the evaluation and restoration of the balance of the gut microbiome, leading each patient to get the most out of it by restoring the balance of the microbiome. Having conducted research characterizing the microbiome in children with ASD versus neurotypical children, finding critical differences. We were able to show that a change in the type of diversity of the microbiome typical of children with ASD produced marked improvement in the areas of communication, socialization and behaviors, in a 2-year follow-up study. This correlates with research published by the scientific community dedicated to the study of the human microbiome in children with ASD.

Children with ASD present abnormalities in the microbiome and from this arise affectations in various devices and systems that in the initial stage of our protocol will be evaluated individually, allowing us to establish guidelines for an improvement in the altered parameters in each patient.

Aflora is also a pioneers in FMT (Fecal microbiota Transplantation) in the world in children with ASD. 

This part of the treatment focuses on the child’s initial evaluation in a personalized way of their microbiome.

The microbiome regulates:

1 – Digestive health

2 – Immune health

3 – Metabolic

4 – Nutrition at the cellular level

5 – Xeno Biome (cleaning process of environmental toxins)

6 – Epigenome (gene activator or suppressor).

This microbiome must be healthy in order for all these systems to work synergistically. The objective of STAGE A of ABC PROTOCOL is to address gut microbiome imbalances, to be receptive to the rest of the therapies in stages B and C of our protocol, specifically be recipient and achieve maximum potential for stem cell transplant.

Synergy between MSC and microbiome disorder: Mesenchymal stem cells have also been studied as a solution for gut microbiome disorders, as they regulate immune cell activity and improve intestinal barrier function. Additionally, MSCs modulate the microbiome and reduce inflammation in the gastrointestinal tract by secreting growth factors and anti-inflammatory molecules that promote tissue repair and suppress inflammatory cell activity.

In this way, mesenchymal stem cells have the potential for synergy with the treatment of the intestinal microbiome by potentiating the therapeutic effects and reducing the regeneration time of the intestinal tissue.


MeRT is a novel treatment based on repetitive transcranial magnetic stimulation (rTMS) technology together with a q-EEG (quantitative electroencephalogram) and an EKG (electrocardiogram) that allows individualized reestablishment of healthy brain communication in patients with autism.

It is a non-invasive, painless and drug-free alternative that seeks to recover the functionality of the brain.

This part of the process begins with a quantitative electroencephalogram (q-EEG), which records and analyzes brain activity, its pattern of functioning, and the state of neuronal synchronization. Based on the results obtained, our medical team designs a personalized treatment protocol that aims to stimulate the areas of the brain that could be optimized, promoting effective brain communication and a better quality of life.

In autism, the patient’s brain is like an orchestra that has all the instruments, the cello, the violin, the piano, etc., but it lacks a reliable director.

The occipital area (the back) is in charge of receiving all the information from the environment, what we see, what we hear, what we touch, etc., and the frontal area is responsible for processing and analyzing the information received in the occipital area. It is also responsible for language, impulse regulation and control of emotions. By not having a reliable director, many patients with autism may have a “short circuit” in the middle that does not allow the information received to be processed, understood, communicated and executed properly.

MeRT therapy seeks to provide a reliable director to the patient in order to properly connect both areas of the brain and thus have more optimal brain function.

The functional recovery of the brain is the main objective of this part of the treatment.

Some of the benefits found when applying this therapy include:

  • Improved eye contact.
  • Language improvements.
  • Decrease in stereotypes.
  • Improvements in the quality and quantity of sleep.
  • Increased concentration and focus.
  • Improves mood.
  • Greater attention span.
  • Greater sociability and motivation.
  • Greater motivation.
  • Improved clarity of thought.
  • Improvements in learning.
  • Improvements in response time.
  • Increased awareness of the world around you.

 Synergy between MeRT therapy and mesenchymal stem cells: By jointly applying MeRT therapies and mesenchymal stem cell (MSC) transplantation, a synergy is created where both therapies potentiate their effects, there scientific  research proving that they can complement each other, finding that transcranial magnetic stimulation can improve the efficacy of MSC therapy by increasing the migration of cells from the area of administration to the brain and potentiating tissue repair by alleviating inflammation, secreting neurotrophic factors, promoting neurogenesis, also increasing the neuroplasticity capacity of the brain.


 Regeneration Clinic of Panama is a Regenerative Medicine clinic specialized in treatments with Mesenchymal Stem Cells derived from Wharton’s Jelly from the human Umbilical Cord.

We have a professional team that will provide you with personalized attention at each steps of this ABC process.

We have researched possible factors that contribute to the development of Autism Spectrum Disorder (ASD), and we see a strong relationship between gut inflammation and brain inflamation as well.

With tissues that are inflamed for a long time, we will not only see a decrease in their functional capacity at the moment, but their normal development is also be affected. In patients with ASD, persistent inflammation in some areas of the brain can drastically affect proper neurodevelopment, accentuating and prolonging symptoms.

Mesenchymal stem cells have emerged as an option that has shown benefits in the treatment of ASD. Mesenchymal stem cells have anti-inflammatory and regenerative properties and have the ability to regulate the immune system. These properties are necessary to reduce inflammation in the brain and intestine, which have been associated with ASD, and stimulate the proper development of the central nervous system, improving the symptoms present in autism.

By reducing inflammation and stimulating neuroplasticity, improvement in behavior, language, and communication skills has been shown in patients with ASD.


Citations and Scientific References

Our medical unit is highly esteemed for partnering globally with fellow researchers on scientific studies and contributing to respected scientific journals.

View References

Visit website ABC Autism